MP
BIOSU

Mangrove Partners’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Mangrove Partners’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-400,941
Closed -$4M – 599
2022
Q1 		$4M Buy
400,941
+941
+0.2% +$9.4K 0.22% 186
2021
Q4 		$4M Buy
+400,000
New +$4.01M 0.24% 145

Other funds holding BIOSU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return

Mangrove Partners's BIOSU Position: Q2 2022 in Review

Mangrove Partners sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q2 2022, closing a stake of 400,941 shares — an estimated $4M sold.

Mangrove Partners first reported a position in BIOSU in Q4 2021 and held it in 2 quarters. The position peaked at $4M in Q1 2022. 24 funds tracked by Wall St. Rank hold BIOSU as of Q2 2022.

  • Mangrove Partners reported no remaining BioPlus Acquisition Corp. Unit position as of Q2 2022 after selling out during the quarter.
  • Mangrove Partners sold 400,941 BioPlus Acquisition Corp. Unit shares in Q2 2022, an estimated $4M.
  • Mangrove Partners first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 2 quarters.
  • Mangrove Partners's BioPlus Acquisition Corp. Unit position peaked at $4M in Q1 2022.
  • 24 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q2 2022.

Based on Mangrove Partners's 13F filing for Q2 2022, filed 15 Aug 2022.